ResearcherUniversity of MichiganActive in the last 2 years

Victoria M. Valvo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0004-5837-4141; OpenAlex author ID A5092540224. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-24-0210 ↗
Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer. Co-author DOI 10.1172/jci.insight.168824 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Leslie A. Parsels · 2 shared papers, 2024–2025 · strength 0.35
- Paper Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancrea… DOI 10.1158/1535-7163.mct-24-0210 ↗
- Paper Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer. DOI 10.1172/jci.insight.168824 ↗
Theodore Steven Lawrence · 2 shared papers, 2024–2025 · strength 0.35
- Paper Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancrea… DOI 10.1158/1535-7163.mct-24-0210 ↗
- Paper Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer. DOI 10.1172/jci.insight.168824 ↗
Meredith Ann Morgan · 2 shared papers, 2024–2025 · strength 0.35
- Paper Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancrea… DOI 10.1158/1535-7163.mct-24-0210 ↗
- Paper Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer. DOI 10.1172/jci.insight.168824 ↗
Qiang Zhang · 2 shared papers, 2024–2025 · strength 0.35
- Paper Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancrea… DOI 10.1158/1535-7163.mct-24-0210 ↗
- Paper Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer. DOI 10.1172/jci.insight.168824 ↗
Vaibhav Sahai · 2 shared papers, 2024–2025 · strength 0.35
- Paper Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancrea… DOI 10.1158/1535-7163.mct-24-0210 ↗
- Paper Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer. DOI 10.1172/jci.insight.168824 ↗
Alnawaz Rehemtulla · 1 shared paper, 2025 · strength 0.18
- Paper Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancrea… DOI 10.1158/1535-7163.mct-24-0210 ↗
Eileen S. Carpenter · 1 shared paper, 2025 · strength 0.18
- Paper Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancrea… DOI 10.1158/1535-7163.mct-24-0210 ↗
David M. Karnak · 1 shared paper, 2025 · strength 0.18
- Paper Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancrea… DOI 10.1158/1535-7163.mct-24-0210 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.